Holger Weis
CIK 1846984 · Chief Executive Officer · last filed 2026-06-04
Holger Weis is a Chief Executive Officer who has filed 11 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for JUNS, was dated Jun 4, 2026. Across all open-market trades the lifetime net is +$91.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $15.9K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$15.9K
3
11
$91.5K
Holdings By Company
Recent Filings
11 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-04 | JUNS | Grant (A) | — | $0 | EDGAR |
| 2026-05-27 | TCRT | Grant (A) | +3,700 | $8.8K | EDGAR |
| 2025-08-20 | TCRT | Grant (A) | — | $0 | EDGAR |
| 2025-07-07 | TCRT | Grant (A) | — | $0 | EDGAR |
| 2025-04-15 | TCRT | Grant (A) | — | $0 | EDGAR |
| 2025-01-24 | JUNS | Exer (M) | +10,781 | $0 | EDGAR |
| 2024-06-10 | TCRT | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | TCRT | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | TCRT | Grant (A) | +40,000 | $0 | EDGAR |
| 2021-09-03 | Alaunos Therapeutics, Inc. (ZIOP) Delisted | Buy (P) | +50,000 | $91.5K | EDGAR |